Lidoderm

Type: Product

Name: Lidoderm

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Despite Large Gains, This Stock Is Still a Buy

Brian is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.Rumors of mergers and takeovers have overshadowed the good fundamental news surrounding Actavis (NYSE: ACT) If you’re ... [Published Motley Fool - May 20 2013]

Entities: Actavis, Drugs, Alexion Pharmaceuticals Inc, Motley Fool, Warner Chilcott plc

First reported May 09 2013 - Updated May 09 2013 - 1 reports

UPDATE: Jefferies Raises PT on Endo Health Solutions on Greater Visibility

In a report published Thursday, Jefferies analyst Corey Davis reiterated a Buy rating on Endo Health Solutions (NASDAQ: ENDP), and raised the price target from $44.00 to $47.00.In the report, Davis noted, “Light 1Q revenues were attributable to Lidoderm ... [Published Benzinga.com - May 09 2013]

Entities: Endo Health Solutions Inc, Corey Davis, Lidoderm

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Actavis

Earnings Beat at Endo Health, Sales Slip - Analyst Blog

Endo Health Solutions’ (ENDP) first quarter 2013 earnings (excluding special items) of $1.09 per share beat the Zacks Consensus Estimate by a penny and increased 25% from the year-ago period. Earnings in the first quarter of 2013 were aided by lower ... [Published Quote.com Canada - May 08 2013]

Entities: Endo Pharmaceuticals Holdings Incorporated, Lidoderm, Actavis, Drugs

First reported May 07 2013 - Updated May 07 2013 - 2 reports

Endo Health Solutions Management Discusses Q1 2013 Results - Earnings Call Transcript

8:30 AM ETOperatorGood day, ladies and gentlemen, and welcome to the Q1 2013 Endo Health Solutions Inc. Earnings Conference Call. My name is Gary, and I will be your coordinator for today. [Operator Instructions] As a reminder, this call is being recorded ... [Published Seeking Alpha - May 07 2013]

Entities: Opana ER, Endo Health Solutions Inc, Lidoderm

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) Reports First Quarter Financial Results

Endo Health Solutions Inc. (ENDP) swung to a first-quarter profit amid fewer write-downs and other items, as well as a modest revenue increase as strong sales growth in its generic segment offset declines in other businesses. New Chief Executive Rajiv ... [Published BioSpace - May 07 2013]

Entities: Endo Health Solutions Inc, Endo Pharmaceuticals Holdings Incorporated, Lidoderm, Writedowns

First reported May 07 2013 - Updated May 07 2013 - 2 reports

Endo Health turns 1Q profit, affirms 2013 forecast

MALVERN, Pa. -- Endo Health Solutions Inc. turned a first-quarter profit, reversing a lost at the start of 2012, when the drug developer absorbed a sizeable pre-tax charge tied to a settlement and license agreement.The Malvern, Pa., company said Tuesday ... [Published Equities.com - May 07 2013]

Entities: Opana ER, Lidoderm, Drugs, Endo Health Solutions Inc

First reported May 07 2013 - Updated May 07 2013 - 2 reports

Endo Reports First Quarter Financial Results

/PRNewswire/ -- (Nasdaq: ENDP) today reported first quarter 2013 total revenues of $709 million, compared to $691 million for the same quarter of 2012. Endo reported first quarter 2013 net income of $15 million, compared to a reported net loss of $87 ... [Published Freshnews.com - May 07 2013]

Entities: Endo Pharmaceuticals Holdings Incorporated, Opana ER, Lidoderm

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Endo Pharmaceuticals Holdings Earnings: Your Sneak Peek to the Big Announcement

Endo Pharmaceuticals Holdings ( NASDAQ:ENDP ) will report earnings before markets open on Tuesday, May 7th. Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, ... [Published Wall St. Cheat Sheet - May 07 2013]

Entities: Endo Pharmaceuticals Holdings Incorporated, Percodan, Lidoderm

First reported Apr 22 2013 - Updated Apr 22 2013 - 2 reports

Express Scripts Research Shows Prescription Drug Utilization Declines for Payers of Workers' Compensation

/PRNewswire/ -- Express Scripts' (NASDAQ: ESRX) industry-leading prescription management programs drove down utilization of prescription drugs for workers' compensation payers last year even though overall drug trend rose, according to new research released ... [Published NewsBlaze - Apr 22 2013]

Entities: Express Scripts Inc, Workers, Drugs

First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

Shares of ENDP Up 27.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Endo Pharmaceuticals (NASDAQ:ENDP) on January 24th, 2013 at $28.23. In approximately 3 months, Endo Pharmaceuticals has returned 27.52% as of today's recent price of $36.00.In the past 52 weeks, shares of Endo Pharmaceuticals ... [Published Comtex SmarTrend - Apr 19 2013]

Entities: Endo Pharmaceuticals Holdings Incorporated, Stocks, Percodan, Lidoderm

First reported Feb 17 2013 - Updated Feb 17 2013 - 1 reports

LIDODERM (Lidocaine) Patch [Endo Pharmaceuticals Inc.]

Updated Date: Feb 15, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 17 2013]

Entities: Lidoderm, Lidocaine, Endo Pharmaceuticals Holdings Incorporated

First reported Feb 15 2013 - Updated Feb 15 2013 - 1 reports

LIDODERM (Lidocaine) Patch [Endo Pharmaceuticals Inc.]

Updated Date: Feb 15, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 15 2013]

Entities: Lidoderm, Lidocaine, Endo Pharmaceuticals Holdings Incorporated

Quotes

Market Report, "Teikoku Pharma USA Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" , published

Market Report, "Teikoku Pharma USA, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Pro ... [Published Live-PR.com - May 20 2013]

...I continue to be very optimistic about the future of Endo," said Rajiv De Silva, president and CEO of Endo. "Since joining the company I have focused on assessing our current strategy and operations with a view to identifying our best opportunities for growth and improving profitability. I look forward to sharing these plans in the months ahead." ENDO PHARMACEUTICALS

Endo Reports First Quarter Financial Results [Published Freshnews.com - May 07 2013]

...assessing our current strategy and operations with a view to identifying our best opportunities for growth and improving profitability," he said. "I look forward to sharing these plans in the months ahead." Endo Health reported a profit of $15.3 million, or 14 cent a share, compared with a year-earlier loss of $87.3 million, or 75 cents a share...

Endo Health Swings to First-Quarter Profit On Strong Generic Drug Sales [Published Capital.gr - May 07 2013]

...I continue to be very optimistic about the future of Endo," said Rajiv De Silva, president and CEO of Endo. "Since joining the company I"

Endo Reports First Quarter Financial Results [Published Bio-Medicine - May 07 2013]

More Content

sort by: Date \| Relevance
New Routes in Drug Delivery [Published Pharmaceutical & Medical Packaging News - 21 hours ago]
Despite Large Gains, This Stock Is Still a Buy [Published Motley Fool - May 20 2013]
Market Report, "Teikoku Pharma USA, Inc. - Phar... [Published Live-PR.com - May 20 2013]
Endo Pharmaceuticals Stock Rating Reaffirmed by... [Published Mideast Time - May 14 2013]
Endo Loses Bid to Thwart Generic Versions of Op... [Published Washington Post - May 10 2013]
Teikoku Pharma USA, Inc. - Pharmaceuticals & He... [Published TransWorldNews - May 10 2013]
Endo Pharmaceuticals Stock Rating Reaffirmed by... [Published American Banking News - May 09 2013]
UPDATE: Jefferies Raises PT on Endo Health Solu... [Published Benzinga.com - May 09 2013]
Review Of Depomed First Quarter 2013 Results [Published Seeking Alpha - May 09 2013]
Earnings Beat at Endo Health, Sales Slip - Anal... [Published Quote.com Canada - May 08 2013]
Endo Health Solutions Management Discusses Q1 2... [Published Seeking Alpha - May 07 2013]
Endo Health Solutions Inc. (Formerly Known as E... [Published BioSpace - May 07 2013]
Endo Health turns 1Q profit, affirms 2013 forecast [Published Equities.com - May 07 2013]
Endo Reports First Quarter Financial Results [Published Freshnews.com - May 07 2013]
Endo Health Swings to First-Quarter Profit On S... [Published Capital.gr - May 07 2013]
Endo Reports First Quarter Financial Results [Published Bio-Medicine - May 07 2013]
Endo Reports First Quarter Financial Results PR... [Published Yahoo! Finance - May 07 2013]
Endo Reports First Quarter Financial Results [Published KCAU-TV - May 07 2013]
Endo Reports First Quarter Financial Results [Published Street Insider - May 07 2013]
Endo Pharmaceuticals Holdings Earnings: Your Sn... [Published Wall St. Cheat Sheet - May 07 2013]
Express Scripts Research Shows Prescription Dru... [Published NewsBlaze - Apr 22 2013]
Express Scripts Research Shows Prescription Dru... [Published Bio-Medicine - Apr 22 2013]
Express Scripts Research Shows Prescription Dru... [Published WOWK - Apr 22 2013]
Shares of ENDP Up 27.5% Since Uptrend Call on S... [Published Comtex SmarTrend - Apr 19 2013]
Trading Higher on Heavy Volume are Shares of En... [Published Scottrade - Apr 17 2013]
Phosphagenics extends pact with Nippon Zoki Pha... [Published PharmaBiz - Apr 04 2013]
Endo records large loss on unit write-down [Published Philadelphia Inquirer - Feb 28 2013]
Endo Health Solutions names new CEO [Published Philadelphia Inquirer - Feb 26 2013]
Technology Can Ease the Pain for Individuals an... [Published Lux Populi - Feb 23 2013]
LIDODERM (Lidocaine) Patch [Endo Pharmaceutical... [Published DailyMed Drug Label Updates for the last seven ... - Feb 17 2013]